Exploring the Pharmacological Potential of Hibiscus Acetosella: GC-MS-Based Compound Analysis

Background Bioactive compounds derived from medicinal plants have gained prominence in the pharmaceutical industry due to their therapeutic potential and role in enhancing health and disease resistance.AimsObjectives The present study aims to identify the bioactive phytochemicals present in the ethanolic leaf extract of cranberry hibiscus Hibiscus acetosella using Gas Chromatography-Mass Spectrometry GC-MS and to explore their potential pharmacological propertiesMethods Ethanolic extracts of cranberry hibiscus leaves were subjected to GC-MS analysis to detect and characterize the phytochemical constituents. Identification was based on retention time molecular weight and mass spectral data which were matched against the NIST 2008 GC-MS library.Results A total of 27 bioactive compounds were identified from the extract. Major constituents included ethane 11-diethoxy 1-propanol 2-methyl 1-propene 3-fluoro acetaldehyde carbamic acid monoammonium salt 3-aminobenzhydrazide and cyclohexane1-ethenyl-1-methyl-24-bis1-methylethenyl. These compounds are associated with a wide range of pharmacological activities including antimicrobial antioxidant anti-inflammatory antidiabetic antifungal antibacterial vasodilatory and potential anticancer effects.Conclusion The GC-MS analysis confirms that cranberry hibiscus leaf extract is rich in therapeutically valuable phytochemicals. These findings suggest that it could serve as a promising source for the development of crude drugs and novel therapeutic agents in modern medicine.